Share price · ANL
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Adjusted for stock splits · Data via Databento
Unusual price moves
Days when ANL's shares moved far more than they usually do, with what was announced that day or the session before. An announcement on the same day does not show that it caused the move. How the days are picked
- 15 Oct 2026+11.1%
- 13 Oct 2026-17.3%
Nothing announced by ANL that day or the session before.
- 8 Oct 2026+10.4%
Nothing announced by ANL that day or the session before.
- 15 Jul 2026+15.5%
Nothing announced by ANL that day or the session before.
- 29 Apr 2026+15.8%
Nothing announced by ANL that day or the session before.
- 30 Jan 2026+62.8%
Nothing announced by ANL that day or the session before.
- 29 Jan 2026+88.2%
Nothing announced by ANL that day or the session before.
- 26 Jan 2026+21.7%
Nothing announced by ANL that day or the session before.
- 23 Jan 2026+28.9%
Nothing announced by ANL that day or the session before.
- 30 Dec 2025-17.2%
Share of unusual movement by asset
For each asset, the share of ANL's own-move activity since 2 Jul 2024 that fell on the session of one of the asset's own announcements or the session after it. Large moves count for much more than small ones. A session shared by several assets is split between them. A share is shown once an asset has at least 8 event days; below that, its events are listed instead.
| Asset | Event days | Share of unusual movement |
|---|---|---|
| Other company news (earnings, financing, releases naming no asset) | — | 7% |
| Sessions with no dated event | — | 93% |
No dated announcements about its assets since 2 Jul 2024.
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 2 | EP4Small molecule | Non-Small Cell Lung CancerColorectal Cancer |
Discontinued programmes (1)
Development of these assets stopped. Each page states the sourced discontinuation and keeps the trials as evidence history.
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
Annual history (4 years)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2024-FY | $5.0M | $45M | $61M | $13M-$52M operating cash flow | report ↗ |
Insider transactions
Open-market activity, trailing 12 months: 0 purchases ($0), 7 sales ($411K). Awards, option exercises and tax-withholding rows are listed below but excluded from these totals.
| Source | ||||||
|---|---|---|---|---|---|---|
| 2026-09-30 | Ji Ping · director | Open-market sale | 5,000 | $16.03 | $80K | Form 4 |
| 2026-09-30 | Ji Ping · director | Open-market sale | 5,000 | $15.95 | $80K | Form 4 |
| 2026-09-29 | Ji Ping · director | Open-market sale | 214 | $15.77 | $3K | Form 4 |
| 2026-09-22 | Ji Ping · director | Open-market sale | 5,000 | $16.63 | $83K | Form 4 |
| 2026-08-26 | Ye Xiaofeng · CFO | Open-market sale | 5,667 | $14.25 | $81K | Form 4 |
| 2026-08-24 | Ye Xiaofeng · CFO | Open-market sale | 6,000 | $13.98 | $84K | Form 4 |
| 2026-06-10 | Ji Ping · director | Other (see filing) | 136,667 | — | — | Form 4 |
| 2026-05-13 | LU YANG · director, CEO, 10% owner | Open-market sale | 10 | $13.18 | $132 | Form 4 |
Institutional holders
From SEC Form 13F filings for the quarter ended 2026-03-31 (filed up to 45 days later). 26 reporting institutions held 11.6M shares ($79.5M, 29.0% of shares outstanding).
| # | Institution | Shares | Value |
|---|---|---|---|
| 1 | Venrock Adviser, LLC | 3,212,731 | $22.2M |
| 2 | Cormorant Asset Management, LP | 2,897,857 | $20.1M |
| 3 | Squadron Capital Management LLC | 1,265,231 | $8.8M |
| 4 | Balyasny Asset Management L.P. | 877,846 | $6.1M |
| 5 | MILLENNIUM MANAGEMENT LLC | 681,775 | $4.7M |
| 6 | Casdin Capital, LLC | 538,461 | $3.7M |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 538,461 | $3.7M |
| 8 | SUPERSTRING CAPITAL MANAGEMENT LP | 414,852 | $2.9M |
| 9 | Woodline Partners LP | 209,259 | $1.4M |
| 10 | Affinity Asset Advisors, LLC | 164,748 | $1.1M |
| 11 | UBS Group AG | 122,261 | $846K |
| 12 | AMERIPRISE FINANCIAL INC | 120,156 | $831K |
| 13 | ADAR1 Capital Management, LLC | 117,909 | $816K |
| 14 | Tidal Investments LLC | 66,034 | $457K |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 66,000 | $457K |